Topic: How To Invest


TD HEALTH SCIENCES FUND $15.19 (CWA Rating: Speculative) (TD Asset Management, P.O. Box 7500, Station A, Toronto, Ontario M5W 1P9. 1-800-463-3863; Web site: No load — deal directly with the bank) mainly invests in large-capitalization health-care stocks and earlier-stage biotechnology shares in the U.S. The fund’s managers believe these firms will benefit from increased health spending spurred by an aging population.

The $151.7-million TD Health Sciences Fund’s top holdings include Gilead Sciences, Alexion Pharmaceuticals, Teva Pharmaceutical, Baxter International, Vertex Pharmaceuticals, Medco Health Solutions, Wyeth, Roche Holdings, Henry Schein Inc. and Schering Plough.

TD Health Sciences Fund lost about 7.8% in Canadian dollars in the year ended August 31, 2009, compared to a loss of 15.6% for the S&P 500 (also in Canadian funds). The fund’s MER is 2.68%.

TD Health Sciences Fund is still a buy.

Comments are closed.